[go: up one dir, main page]

CA3173866A1 - Inhibiteurs de la replication du virus de l'immunodeficience humaine - Google Patents

Inhibiteurs de la replication du virus de l'immunodeficience humaine Download PDF

Info

Publication number
CA3173866A1
CA3173866A1 CA3173866A CA3173866A CA3173866A1 CA 3173866 A1 CA3173866 A1 CA 3173866A1 CA 3173866 A CA3173866 A CA 3173866A CA 3173866 A CA3173866 A CA 3173866A CA 3173866 A1 CA3173866 A1 CA 3173866A1
Authority
CA
Canada
Prior art keywords
formula
mmol
another aspect
stirred
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3173866A
Other languages
English (en)
Inventor
Eric P Gillis
Kyle E. Parcella
Gautam Dalwadi
Dawn D. PARKER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ViiV Healthcare UK No 5 Ltd
Original Assignee
ViiV Healthcare UK No 5 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ViiV Healthcare UK No 5 Ltd filed Critical ViiV Healthcare UK No 5 Ltd
Priority claimed from PCT/IB2021/053046 external-priority patent/WO2021209900A1/fr
Publication of CA3173866A1 publication Critical patent/CA3173866A1/fr
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition pharmaceutique comprenant le composé représenté par la formule Ia, formule Ib, formule Ic ou formule Id, ou un sel pharmaceutiquement acceptable de celui-ci. (Formule Ia), (Formule Ib), (Formule Ic), (Formule Id)
CA3173866A 2020-04-15 2021-04-13 Inhibiteurs de la replication du virus de l'immunodeficience humaine Pending CA3173866A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063010196P 2020-04-15 2020-04-15
US63/010,196 2020-04-15
PCT/IB2021/053046 WO2021209900A1 (fr) 2020-04-15 2021-04-13 Inhibiteurs de la réplication du virus de l'immunodéficience humaine

Publications (1)

Publication Number Publication Date
CA3173866A1 true CA3173866A1 (fr) 2021-10-21

Family

ID=84487897

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3173866A Pending CA3173866A1 (fr) 2020-04-15 2021-04-13 Inhibiteurs de la replication du virus de l'immunodeficience humaine

Country Status (1)

Country Link
CA (1) CA3173866A1 (fr)

Similar Documents

Publication Publication Date Title
US12129255B2 (en) Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication
AU2021256166B2 (en) Inhibitors of human immunodeficiency virus replication
US20240374598A1 (en) Inhibitors of human immunodeficiency virus replication
ES2941240T3 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana
ES2969030T3 (es) Derivados de quinazolinil-indazol y su uso como inhibidores de replicación de virus de inmunodeficiencia humana
EP4114527A1 (fr) Inhibiteurs de la réplication du virus de l'immunodéficience humaine
JP7545414B2 (ja) ヒト免疫不全ウイルス複製阻害剤
EP4038064A1 (fr) Dérivés de 6-oxo-1,6-dihydropyrimidine-2-yl n-substitués utilisés en tant qu'inhibiteurs de la réplication du virus de l'immunodéficience humaine
IL296182A (en) Inhibitors of human immunodeficiency virus replication
CA3173866A1 (fr) Inhibiteurs de la replication du virus de l'immunodeficience humaine
RU2851859C1 (ru) Ингибиторы репликации вируса иммунодефицита человека
RU2804033C2 (ru) Ингибиторы репликации вируса иммунодефицита человека
BR122024007306A2 (pt) Composição farmacêutica que compreende o composto da fórmula ia, fórmula ib, fórmula ic ou fórmula id e uso da mesma para tratamento de infecção por hiv
EA044806B1 (ru) Ингибиторы репликации вируса иммунодефицита человека
BR122024005456A2 (pt) Compostos inibidores de replicação do vírus da imunodeficiência humana, composição farmacêutica compreendendo os mesmos e uso dos referidos compostos no tratamento de infecção por hiv

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220928

EEER Examination request

Effective date: 20220928

EEER Examination request

Effective date: 20220928

EEER Examination request

Effective date: 20220928

EEER Examination request

Effective date: 20220928

EEER Examination request

Effective date: 20220928

EEER Examination request

Effective date: 20220928